Exploring Health LLC features proprietary screening platforms to discover promising anti-metastatic candidates from your compound libraries.

Hit compounds identified in primary screening undergo rigorous downstream validation across our diverse panel of in vitro cell models and in vivo metastatic animal models. Our fully equipped high-throughput screening workflow integrates automated microplate dispensers, cell incubators, microplate readers, together with dedicated analysis software and analytical pipelines, fully supporting your end-to-end professional drug screening projects.